Syrs price target
WebNov 7, 2024 · Is SYRS a Good Stock to Buy, According to Analysts? Turning to Wall Street, SYRS is a Strong Buy based on four unanimous Buy ratings. The average Syros Pharmaceuticals price target is $39.25, implying a massive 866.75% upside potential. Conclusion: Should You Consider Syros Pharmaceuticals Stock? WebPrice target 24.00 0.00 0.00% The 5 analysts offering 1 year price forecasts for SYRS have a max estimate of — and a min estimate of —. Analyst rating Based on 6 analysts giving …
Syrs price target
Did you know?
WebThe 5 analysts offering 1 year price forecasts for SYRS have a max estimate of — and a min estimate of —. ... Price target. 24.00 R USD +21.19 +754.09%. The 5 analysts offering 1 year price forecasts for Syros Pharmaceuticals, Inc. have a max estimate of 60.00 and a min estimate of 13.00. Web1 day ago · Syros Pharmaceuticals (SYRS) (Real Time Quote from BATS) $2.73 USD +0.11 (4.20%) Updated Apr 13, 2024 01:37 PM ET Add to portfolio Zacks Rank: 3-Hold 3 Style Scores: F Value F Growth D...
WebSyros Pharmaceuticals, Inc. (SYRS) Stock Price, News, Quote & History - Yahoo Finance U.S. markets open in 6 hours 59 minutes Dow Futures Nasdaq Futures Russell 2000 Futures … WebApr 10, 2024 · Syros Pharmaceuticals, Inc. (SYRS) Reports Q3 Loss, Misses Revenue Estimates. Syros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises …
WebSYRS Stock 12 Months Forecast. $24.00. (858.08% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Syros Pharmaceuticals in the last 3 months. The … WebSYRS Syros Pharmaceuticals Inc. Analyst Estimates & Rating – WSJ Syros Pharmaceuticals Inc. SYRS (U.S.: Nasdaq) View All companies 12:18 PM EDT 03/29/23 …
WebApr 15, 2024 · Several equities analysts have weighed in on SYRS shares. Piper Sandler cut their price target on Syros Pharmaceuticals from $27.00 to $20.00 and set an “overweight” rating for the company in ...
WebSYRS's average price target has moved up $19.38 over the prior 18 months. Over the past 47 weeks, SYRS's average upside potential has been 1,920.65%. SYRS Broker … pottery barn spiderman sheetsWebOct 18, 2024 · Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of … toulon tangerWebFind real-time SYRS - Syros Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. SYRS - Syros Pharmaceuticals Inc Stock quote - … pottery barn sports backpackWebSYRS's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! Dividend.com: The #1 Source For Dividend Investing. ... Price target upside according to sell-side analysts. Quant Recommendation - SYRS ... SEll SYRS shares when price recovers. sell date (estimate) N/A. Avg Price Recovery. N/A. Avg yield on cost. N/A. toulon streetWebBased on 6 Wall Street analysts offering 12 month price targets for Protagonist Therapeutics in the last 3 months. The average price target is $34.50 with a high forecast of $41.00 and a low forecast of $28.00. The average price target represents a 53.88% change from the last price of $22.42. Highest Price Target $41.00 Average Price Target $34.50 toulon tarbesWebMar 9, 2024 · InvestorsObserver is giving Syros Pharmaceuticals Inc (SYRS) an Analyst Rating Rank of 73, meaning SYRS is ranked higher by analysts than 73% of stocks. The average price target for SYRS is $16 and analyst’s rate the stock as a Strong Buy. toulon to niceWebApr 6, 2024 · According to 11 stock analysts, the average 12-month stock price forecast for SYRS stock is $ 143.82 , which predicts an increase of 5,641.32%. The lowest target is $ … toulon transfermarkt